The Research and Development Team at Actinium Pharmaceuticals is dedicated to pioneering new advancements in targeted radioimmunotherapies for advanced cancers. This team is responsible for translating innovative scientific research into viable preclinical and clinical development programs, overseeing the design and development of new therapeutic compounds, ensuring seamless manufacturing processes, and driving corporate development initiatives to support the company's R&D objectives. Through their collaborative efforts, they aim to bring transformative cancer treatments from concept to reality.
View all